Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemophilia A × recombinant FVIIa × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

emicizumab 4 Factor VIII 2 recombinant FVIIa 1 anti-inhibitor coagulant complex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡